BioCorRx Inc. (BICX)

[RBC-]

Pretty excited to potentially have the only naltrexone implant to be FDA approved after meetings with state and federal officials saying there is demand and need for it. Coupled with a possible better naltrexone injection in the pipeline than the current leading option gives me confidence in the buyout potential of biocorrx.

Adding clinics, like the 5 this past quarter, raising revenue makes me wonder if I even want a buyout. If we have the only FDA approved implant, we will be offered in every clinic nationwide. Revenues coming in like a flood.

Prediction: IND application sent, clinics added, grants received to pay for the clinical studies, fast tracked IND acceptance, government $ paying for the implant to patients, revenues sky rocket, BICX101 continues, buyout.